Q4 2014 Holdings
Filed 2015-02-13 | 16 holdings | $352.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Prosensa | Common | N71546100 | $116.5K | 6,213,924 | 33.1% |
| Paratek | Common | 699374302 | $50.0K | 1,301,413 | 14.2% |
| Sientra | Common | 82621J105 | $36.9K | 2,199,012 | 10.5% |
| Portola | Common | 737010108 | $26.4K | 930,682 | 7.5% |
| Supernus(SUPN) | Common | 868459108 | $23.9K | 2,879,328 | 6.8% |
| Lombard Medical | Common | G55598109 | $22.1K | 3,473,452 | 6.3% |
| Proteon | Common | 74371L109 | $20.3K | 2,017,872 | 5.8% |
| Dicerna(DRNAUSD) | Common | 253031108 | $19.4K | 1,182,196 | 5.5% |
| Cempra | Common | 15130J109 | $16.8K | 714,285 | 4.8% |
| Amarin | Spons ADR | 023111206 | $7.8K | 8,087,486 | 2.2% |
| Regulus | Common | 75915K101 | $5.2K | 327,350 | 1.5% |
| Zogenix | Common | 98978L105 | $3.2K | 2,335,218 | 0.9% |
| Hyperion | Common | 44915N101 | $1.5K | 62,500 | 0.4% |
| Oncogenex Pharma | Common | 68230A106 | $1.4K | 603,740 | 0.4% |
| Anthera | Common | 03674U201 | $679 | 437,994 | 0.2% |
| Epirus Biopharma | Common | 98887C204 | $44 | 7,896 | 0.0% |